Our study provides an opportunity to develop a novel strategy for melanoma treatment, to specifically induce ATF3 expression in tumor stromal cells, which could be combined with other conventional and/or innovative treatments to enhance melanoma therapy in the future. This evidence concerns the gene ATF3 and melanoma.